U.S. Sanger Sequencing Market to Hit USD 4.25 Billion by 2032 as Demand for Reliable Genetic Sequencing in Healthcare Intensifies.Austin, July 16, 2025 (GLOBE NEWSWIRE) -- Sanger Sequencing Market ...

This infographic highlights single-cell sequencing workflows, multiomics integration and emerging applications that are ...

However; single nucleotide polymorphism (SNP) genotyping often remains dependent on arrays, leaving genotyping and NGS ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...

Powerful new applications of what is known as next-generation sequencing are now helping with identification of degraded ...

UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, known as ...

PRNewswire/ -- n6 is proud to announce a strategic partnership with SeqCenter, who is launching a groundbreaking full-length ...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

As predicted the era of universal newborn genomic screening is dawning. The UK and Florida are leading the way.

LOUISVILLE, Ky. (WDRB) -- UofL Health's Brown Cancer Center is the first in the nation to offer a new type of testing.